Jack Ball - 29 Nov 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Jack Ball
Issuer symbol
CTKB
Transactions as of
29 Nov 2022
Net transactions value
+$16,533
Form type
4
Filing time
30 Nov 2022, 18:39:53 UTC
Previous filing
16 Nov 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise $4,266 +10,666 +356% $0.4000* 13,666 29 Nov 2022 Direct
transaction CTKB Common Stock Options Exercise $12,266 +13,333 +98% $0.9200* 26,999 29 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (Right to Buy) Options Exercise $0 -10,666 -100% $0.000000* 0 29 Nov 2022 Common Stock 10,666 $0.4000 Direct
transaction CTKB Stock Option (Right to Buy) Options Exercise $0 -13,333 -100% $0.000000* 0 29 Nov 2022 Common Stock 13,333 $0.9200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/12th of the shares subject to the option shall vest monthly over one year from July 24, 2020.